Lead statistical support for early- and late-phase clinical studies.
Lead the development, execution, and interpretation of statistical analyses.
Lead the development and the adoption of innovative statistical approaches.
Kailera develops therapies that give people the power to transform their lives and elevate their overall health. They are rooted in an entrepreneurial spirit and a team-oriented culture, working together to advance novel therapies for obesity and related conditions.
Function as lead programmer to produce and/or validate tables, listings, figures, and analysis datasets.
Develop/review TFL shells, SDTM and ADaM specifications in collaboration with biostatisticians and other clinical development colleagues.
Work closely with Data Management and Biostatistics to ensure final databases, analyses, and reports are accurate.
Nuvalent is working to create selective medicines designed with the goal to address the needs of patients with cancer using its expertise in chemistry. Nuvalent is an early-stage company bringing together experienced scientists and industry veterans with a proven track record in oncology drug development.
Ownership of scientific and operational statistical work for clinical trials.
Develop study Statistical Analysis Plans and study documents.
Provide statistical expertise in support of interactions with regulatory agencies.
Tarsus is dedicated to attracting and retaining top talent. The company offers comprehensive benefits, bonus, and stock equity to promote work-life balance.
Lead statistical strategy for hematology studies across phases of development.
Oversee generation and validation of TLFs and other statistical outputs.
Contribute to IND, NDA/BLA, and other global submissions.
ClinChoice is a global full-service CRO specializing in clinical development and functional solutions for pharmaceutical, biotechnology, medical device, and consumer health companies. They have over 4,000 professionals in more than 20 countries across the Americas, Europe, and Asia-Pacific.
Responsible for protocol development including study design, sample size calculation, randomization, and statistical analysis plan for assigned studies.
Provide statistical oversight to studies and assure adequate quality and consistency with project requirements.
Responsible for assuring that data for statistical analyses are complete, accurate and consistent.
ClinChoice is a global full-service CRO specializing in clinical development and functional solutions for pharmaceutical, biotechnology, medical device, and consumer health companies. They have over 4,000 professionals in more than 20 countries across the Americas, Europe, and Asia-Pacific with a strong focus on quality, professional development, and supportive culture.
Lead and oversee end-to-end clinical trial operations from study start-up through close-out.
Develop and execute operational plans, timelines, and performance metrics to support successful delivery of assigned studies.
Proactively identify operational risks and implement mitigation strategies to maintain timelines, quality, and compliance.
Centessa Pharmaceuticals plc is a new kind of pharmaceutical company with a deconstructed R&D environment that prioritizes data-driven decision-making led by subject matter experts. Their asset-centric model offers a unique R&D logic that has been applied by single-asset companies to improve productivity.
Design and execute analyses for analytical validation studies.
Perform relevant statistical analyses for studies of varying complexity.
Produce high quality presentations and author documentation.
Natera is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. They aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier and more targeted interventions.